A novel antibody approach for fighting cancer and NETosis-driven inflammatory diseases
Patrys is using deoxymabs to develop revolutionary cancer and inflammatory disease therapies
Please click here to view our latest company presentation.
Please click here to find out more about investing in Patrys.
Level 4, 100 Albert Road
South Melbourne VIC 3205
Australia
ABN 97 123 055 363
Phone +61 3 9670 3273